Investigative Ophthalmology & Visual Science, Vol 36, 24-31, Copyright © 1995 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Immunoreactivity against tau, amyloid precursor protein, and beta- amyloid in the human retina

KU Loffler, DP Edward and MO Tso
Georgiana Dvorak Theobald Ophthalmic Pathology Laboratory, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago College of Medicine 60612.

PURPOSE. Increased immunoreactivity (IR) of beta-amyloid and the amyloid-associated proteins tau and amyloid precursor protein (APP) in the brain have been linked to the pathogenesis of neurodegenerative disorders such as Alzheimer's disease. However, the expression of these proteins has not been investigated in the normal or diseased human retina. METHODS. Using immunohistochemical techniques, we examined the distribution and age-related changes of anti-tau-1, anti-tau-2, anti- APP, and anti-beta-amyloid IR in the human retina at various ages (n = 24), in retinitis pigmentosa (RP, n = 6), and in age-related macular degeneration (ARMD, n = 10). RESULTS. Tau-1 immunoreactivity was intense in the inner retinal layers and did not change with age or in RP. Eyes with ARMD showed less intense staining but exhibited a similar distribution. Tau-2 IR was faint and did not change with age but was mildly increased in the retinal pigment epithelium (RPE) of eyes with RP and in the retina of eyes with ARMD. APP IR was most prominent in the ganglion cell and nerve fiber layer, and it appeared to increase in ganglion cells of older persons and in RPE cells of eyes with RP and ARMD. Beta-amyloid IR was only detected focally in sub-RPE deposits in eyes from older persons. CONCLUSIONS. The proteins investigated in this study are present in the human retina. The staining pattern of tau is different from the brain, but it shows no age-related changes. The increased immunoreactivity of APP in retinal ganglion cells of older eyes and in RPE cells of eyes with RP and ARMD, as well as the patchy staining of beta-amyloid within sub-RPE deposits, might indicate a relationship of these proteins to retinal aging and possibly to retinal degeneration in RP.

This article has been cited by other articles:

				A. Seth, J. Cui, E. To, M. Kwee, and J. Matsubara Complement-Associated Deposits in the Human Retina Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 743 - 750. [Abstract] [Full Text] [PDF]

				L. Guo, T. E. Salt, V. Luong, N. Wood, W. Cheung, A. Maass, G. Ferrari, F. Russo-Marie, A. M. Sillito, M. E. Cheetham, et al. Targeting amyloid-beta in glaucoma treatment PNAS, August 14, 2007; 104(33): 13444 - 13449. [Abstract] [Full Text] [PDF]

				L. V. Johnson, W. P. Leitner, A. J. Rivest, M. K. Staples, M. J. Radeke, and D. H. Anderson The Alzheimer's Abeta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration PNAS, September 3, 2002; 99(18): 11830 - 11835. [Abstract] [Full Text] [PDF]

				R. F. MULLINS, S. R. RUSSELL, D. H. ANDERSON, and G. S. HAGEMAN Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease FASEB J, May 1, 2000; 14(7): 835 - 846. [Abstract] [Full Text]

				P. H. Frederikse, D. Garland, J. S. Zigler Jr., and J. Piatigorsky Oxidative Stress Increases Production of beta-Amyloid Precursor Protein and beta-Amyloid (Abeta) in Mammalian Lenses, and Abeta Has Toxic Effects on Lens Epithelial Cells J. Biol. Chem., April 26, 1996; 271(17): 10169 - 10174. [Abstract] [Full Text] [PDF]